A Study Comparing the Efficacy and Safety Between I-CHOP and R-CHOP in Untreated CD20-Positive Diffuse Large B-cell Lymphoma Patients
Clinical trial NCT02867566 · COMPLETED
Trial details
- NCT number
- NCT02867566
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-22
- Primary completion
- 2019-09-05
- Enrollment
- 420
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.